BJ
BMRN icon

BlackRock Japan’s BioMarin Pharmaceuticals BMRN Stock Holding History

BlackRock Japan’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$17.2M Buy
207,324
+2,243
+1% +$193K 0.06% 365
2016
Q3 		$19M Buy
205,081
+2,358
+1% +$222K 0.06% 337
2016
Q2 		$15.8M Buy
202,723
+5,606
+3% +$477K 0.06% 370
2016
Q1 		$16.3M Sell
197,117
-721
-0.4% -$58.7K 0.06% 343
2015
Q4 		$20.7M Sell
197,838
-143
-0.1% -$14.9K 0.08% 288
2015
Q3 		$20.9M Buy
197,981
+1,521
+0.8% +$203K 0.08% 271
2015
Q2 		$26.9M Buy
196,460
+11,622
+6% +$1.44M 0.1% 226
2015
Q1 		$23M Sell
184,838
-956
-0.5% -$101K 0.09% 255
2014
Q4 		$16.8M Buy
185,794
+14,832
+9% +$1.23M 0.06% 340
2014
Q3 		$12.3M Buy
170,962
+14,972
+10% +$984K 0.05% 385
2014
Q2 		$9.7M Sell
155,990
-15,091
-9% -$912K 0.04% 460
2014
Q1 		$11.7M Buy
171,081
+12,022
+8% +$886K 0.05% 405
2013
Q4 		$11.2M Sell
159,059
-3,666
-2% -$249K 0.05% 421
2013
Q3 		$11.7M Buy
162,725
+14,292
+10% +$950K 0.06% 392
2013
Q2 		$8.27M Buy
+148,433
New +$9.25M 0.04% 495

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Japan's BMRN Position: Q4 2016 in Review

BlackRock Japan increased its BioMarin Pharmaceuticals (BMRN) stake by 1.1% in Q4 2016, buying an estimated $193K and bringing the position to 207,324 shares worth $17.2M. The position accounts for 0.06% of the portfolio, ranked #365.

BlackRock Japan first reported a position in BMRN in Q2 2013 and has held it in 15 quarters since. The position peaked at $26.9M in Q2 2015. 415 funds tracked by Wall St. Rank hold BMRN as of Q4 2016.

  • BlackRock Japan held 207,324 shares of BioMarin Pharmaceuticals worth $17.2M as of Q4 2016.
  • BlackRock Japan bought 2,243 BioMarin Pharmaceuticals shares in Q4 2016, an estimated $193K.
  • BioMarin Pharmaceuticals made up 0.06% of BlackRock Japan's portfolio in Q4 2016, its #365 holding.
  • BlackRock Japan first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's BioMarin Pharmaceuticals position peaked at $26.9M in Q2 2015.
  • 415 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.